Strategic Partnerships Kent Imaging is expanding distribution and integration capabilities, evidenced by recent partnership with New Horizon Medical Solutions and Epic workflow integration for SnapshotNIR. This signals strong channel-building momentum and opportunity to position joint ventures or additional distribution deals in wound care and surgical settings.

Clinical Value Two flagship devices address real-time decision support in wound care, vascular, and surgical areas, with SnapshotNIR improving clinical decision-making and SnapshotGLO enabling bioburden detection. This creates upsell potential with hospitals seeking comprehensive imaging solutions that reduce complications and improve outcomes.

Platform Expansion Recent product launches and software updates, including the Epic integration and ongoing SnapNIR enhancements, indicate a roadmap of platform upgrades. May present opportunities to sell additional modules, services, or bundled packages to current customers upgrading to an integrated imaging ecosystem.

Regulatory Momentum FDA clearance for SnapshotGLO and CE marking for SnapshotNIR, plus Health Canada clearance, reflect regulatory validation that can accelerate procurement cycles in hospitals and clinics. Use this to de-risk adoption discussions and target customers prioritizing compliant imaging tech.

Growth Funding Visible funding activity, including prior $15M investment and a planned $25M Series B, signals investor confidence and potential for accelerated growth. This can open conversations about scaling deployments, international expansion, and financing options or leasing arrangements for mid-size healthcare institutions.